These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 38541700)

  • 1. In Vitro Study of Interleukin-6 when Used at Low Dose and Ultra-Low Dose in Micro-Immunotherapy.
    Jacques C; Marchand F; Chatelais M; Brulefert A; Riffault M; Floris I
    Life (Basel); 2024 Mar; 14(3):. PubMed ID: 38541700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Actives from the Micro-Immunotherapy Medicine 2LMIREG
    Jacques C; Marchand F; Chatelais M; Floris I
    J Inflamm Res; 2024; 17():1161-1181. PubMed ID: 38406323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Special Focus on the Cellular Anti-Inflammatory Effects of Several Micro-Immunotherapy Formulations: Considerations Regarding Intestinal-, Immune-Axis-Related- and Neuronal-Inflammation Contexts.
    Jacques C; Floris I
    J Inflamm Res; 2022; 15():6695-6717. PubMed ID: 36536643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pro-Inflammatory Cytokines at Ultra-Low Dose Exert Anti-Inflammatory Effect In Vitro: A Possible Mode of Action Involving Sub-Micron Particles?
    Floris I; Rose T; Rojas JAC; Appel K; Roesch C; Lejeune B
    Dose Response; 2020; 18(4):1559325820961723. PubMed ID: 33633511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Unitary Micro-Immunotherapy Medicine Interferon-γ (4 CH) Displays Similar Immunostimulatory and Immunomodulatory Effects than Those of Biologically Active Human Interferon-γ on Various Cell Types.
    Jacques C; Chatelais M; Fekir K; Brulefert A; Floris I
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How an Immune-Factor-Based Formulation of Micro-Immunotherapy Could Interfere with the Physiological Processes Involved in the Atopic March.
    Jacques C; Floris I
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultra-Low Dose Cytokines in Rheumatoid Arthritis, Three Birds with One Stone as the Rationale of the 2LARTH
    Jacques C; Floris I; Lejeune B
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34201546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential Role of the Micro-Immunotherapy Medicine 2LALERG in the Treatment of Pollen-Induced Allergic Inflammation.
    Floris I; Chenuet P; Togbe D; Volteau C; Lejeune B
    Dose Response; 2020; 18(1):1559325820914092. PubMed ID: 32269504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Sequential Micro-Immunotherapy Medicine Increases Collagen Deposition in Human Gingival Fibroblasts and in an Engineered 3D Gingival Model under Inflammatory Conditions.
    Ferrà-Cañellas MDM; Munar-Bestard M; Floris I; Ramis JM; Monjo M; Garcia-Sureda L
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Micro-Immunotherapy Sequential Medicine MIM-seq Displays Immunomodulatory Effects on Human Macrophages and Anti-Tumor Properties towards In Vitro 2D and 3D Models of Colon Carcinoma and in an In Vivo Subcutaneous Xenograft Colon Carcinoma Model.
    Jacques C; Marchesi I; Fiorentino FP; Chatelais M; Lilli NL; Appel K; Lejeune B; Floris I
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Micro-Immunotherapy Medicine 2LEID Exhibits an Immunostimulant Effect by Boosting Both Innate and Adaptive Immune Responses.
    Jacques C; Chatelais M; Fekir K; Fauconnier L; Mellier M; Togbe D; Floris I
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding the Mode of Action of a Micro-Immunotherapy Formulation: Pre-Clinical Evidence from the Study of 2LEBV
    Jacques C; Marchand F; Chatelais M; Brulefert A; Floris I
    Life (Basel); 2024 Jan; 14(1):. PubMed ID: 38255717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pro-inflammatory chitosan/poly(γ-glutamic acid) nanoparticles modulate human antigen-presenting cells phenotype and revert their pro-invasive capacity.
    Castro F; Pinto ML; Silva AM; Pereira CL; Teixeira GQ; Gomez-Lazaro M; Santos SG; Barbosa MA; Gonçalves RM; Oliveira MJ
    Acta Biomater; 2017 Nov; 63():96-109. PubMed ID: 28919508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2LARTH
    Floris I; Appel K; Rose T; Lejeune B
    J Inflamm Res; 2018; 11():397-405. PubMed ID: 30464572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotype and cytolytic activity of mouse tumor-bearer splenocytes and tumor-infiltrating lymphocytes from K-1735 melanoma metastases following anti-CD3, interleukin-2, and tumor necrosis factor-alpha combination immunotherapy.
    Yang SC; Fry KD; Grimm EA; Roth JA
    J Immunother (1991); 1991 Oct; 10(5):326-35. PubMed ID: 1790140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
    Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
    J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leaves and pseudostems extract of Curcuma longa attenuates immunoglobulin E/bovine serum albumin-stimulated bone marrow-derived cultured mast cell activation and passive cutaneous anaphylaxis in BALB/c mice.
    Jayasinghe AMK; Kirindage KGIS; Kim SH; Lee S; Kim KN; Kim EA; Heo SJ; Ahn G
    J Ethnopharmacol; 2024 Mar; 321():117529. PubMed ID: 38042384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful combination immunotherapy for the generation in vivo of antitumor activity with anti-CD3, interleukin 2, and tumor necrosis factor alpha.
    Yang SC; Fry KD; Grimm EA; Roth JA
    Arch Surg; 1990 Feb; 125(2):220-5. PubMed ID: 2137327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of moxibustion on colonic low-grade inflammatory response in rats with diarrhea-predominant irritable bowel syndrome based on mast cell degranulation.
    Fang M; Chu H; Song X; Ruan J; Zou L; Li K; Liao L; Ma W; Han X; Zhu J; Wang Z; Fang Y
    Zhongguo Zhen Jiu; 2024 Mar; 44(3):283-294. PubMed ID: 38467503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treating tumor-bearing mice with low-dose gamma-interferon plus tumor necrosis factor alpha to diminish immune suppressive granulocyte-macrophage progenitor cells increases responsiveness to interleukin 2 immunotherapy.
    Pak AS; Ip G; Wright MA; Young MR
    Cancer Res; 1995 Feb; 55(4):885-90. PubMed ID: 7850804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.